Aprotinin during coronary-artery bypass grafting and risk of death
about
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionThe structure of Human Microplasmin in Complex with Textilinin-1, an Aprotinin-like Inhibitor from the Australian Brown SnakeStrategies for blood conservation in pediatric cardiac surgeryUtilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.SSignal detection and monitoring based on longitudinal healthcare dataVariations in the Use of Perioperative Multimodal Analgesic TherapyMisclassification in administrative claims data: quantifying the impact on treatment effect estimates.Neurological complications of cardiac surgery.Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary interventionUse of instrumental variable in prescription drug research with observational data: a systematic review.Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study.The differential impact of delivery hospital on the outcomes of premature infants.Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.Instrumental variable methods in comparative safety and effectiveness researchMethylergonovine maleate and the risk of myocardial ischemia and infarction.Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patientsHealthy user and related biases in observational studies of preventive interventions: a primer for physicians.Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgeryPatterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapyEffect of a medical toxicology admitting service on length of stay, cost, and mortality among inpatients discharged with poisoning-related diagnosesEarly postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era.Plasmin regulation through allosteric, sulfated, small molecules.An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trialsIncorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use.Efficacy of phototherapy for newborns with hyperbilirubinemia: a cautionary example of an instrumental variable analysisModifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns StudyAprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.Reducing bias in the assessment of treatment effectiveness: androgen deprivation therapy for prostate cancer.Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Association of Intensive Care Unit Admission With Mortality Among Older Patients With PneumoniaAngiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgeryIs delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysisAdherence with single-pill amlodipine/atorvastatin vs a two-pill regimenSports and exercise-related tendinopathies: a review of selected topical issues by participants of the second International Scientific Tendinopathy Symposium (ISTS) Vancouver 2012.The effect of tranexamic acid in blood loss and transfusion volume in adolescent idiopathic scoliosis surgery: a single-surgeon experience.External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.
P2860
Q24235627-81163D7C-3353-4A34-BC7F-992FDF56A0D0Q27675944-6CF0A02E-F606-4E11-A65F-34B5013F33E6Q28075771-54705EDA-B09B-4523-A920-A456E0819738Q28538618-F4223D16-918C-4810-960B-91E40728CCEBQ30706851-5CAF0AB9-AD00-4CDC-8F45-FFC3DDDFC34FQ30727438-F974F8C7-9678-4D1E-81D2-F5F580B63627Q30974376-382016D2-5351-4EDD-9CC8-DAB1BB76D81BQ33396480-F66E4F9C-A131-4A45-B3E6-81982CC30C08Q33701953-74C701BD-E35F-45BA-924F-FBB69D8761DDQ33773119-BAA620AE-0483-40E8-9E06-3C8B80B8C741Q33783946-841E5157-C437-4379-A235-ED6B5FAC5462Q33815702-A7F75DC2-7876-42AF-B84E-545F3B0F67A2Q33819482-0E72AD98-7795-4471-B303-F5705CE0F2EBQ33833990-185E4E13-8D4F-48C4-BC17-8EECBF0482D1Q33915337-6ADF96D9-8A2A-4A61-A3BA-45DB9A88D662Q33922033-710DDF38-01FB-4504-985F-A2D37494135DQ33971106-E72CEE92-C2BF-4D23-906E-A126A58AE64DQ34074907-D2C9F06C-BDF2-4EC2-BA8D-47B754C29BE4Q34618556-A8DA2C14-5B61-4729-A432-597E666E49C0Q34799001-CB601C18-5229-4CD9-823A-AC9924D0CC03Q34999581-B013D313-DB8F-41B2-9D89-58C54AA43A08Q35064648-A186CDBC-4185-4243-9C8B-3F11DEDBB955Q35207771-4EE3B5E7-0FA1-472B-85DD-BE9EAD6CB347Q35210123-007E8989-C83E-4E08-B024-49B694D73951Q35234838-45D294A4-19E8-41F6-89E1-7E53856E64E9Q35540006-2032F7A1-60B3-4D94-8F14-3C83874D9EA4Q35591316-BB81806C-39A6-4293-AEC4-4AF3B53D05AEQ35666013-466FF6DE-0A4E-485F-86C6-B2E9D781E50CQ35686628-EA0FF56F-013A-4314-BCE0-8B31E9B3F35FQ35917414-5DD614CE-F6B7-4FA3-B2AE-F79F7C295237Q35958939-2191EBE6-D56B-433A-8C8A-AF57D7C84ACFQ35992569-8B962677-9803-4DC8-9502-D1B0346AE2BCQ36486640-1985AA0C-2D64-4F7F-9844-ED0A8AB20672Q36592295-36B8FD70-FAB7-40C1-88B6-1CF80018DABFQ36657541-29535939-8751-4402-BB20-24D7347FD453Q36775176-55BAD54B-EF4F-418E-B98B-60BD26B84E2DQ36835874-48F97EFD-9723-418D-A54B-2FBCC9F8368DQ36876752-2E7E4086-A136-403D-838B-E9F325914571Q36902300-2496D973-5807-4D42-BA5D-DE51A3B4319AQ36925442-EAEF459D-8209-48A0-A500-A3272526B6D6
P2860
Aprotinin during coronary-artery bypass grafting and risk of death
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Aprotinin during coronary-artery bypass grafting and risk of death
@ast
Aprotinin during coronary-artery bypass grafting and risk of death
@en
Aprotinin during coronary-artery bypass grafting and risk of death
@nl
type
label
Aprotinin during coronary-artery bypass grafting and risk of death
@ast
Aprotinin during coronary-artery bypass grafting and risk of death
@en
Aprotinin during coronary-artery bypass grafting and risk of death
@nl
prefLabel
Aprotinin during coronary-artery bypass grafting and risk of death
@ast
Aprotinin during coronary-artery bypass grafting and risk of death
@en
Aprotinin during coronary-artery bypass grafting and risk of death
@nl
P2093
P3181
P356
P1476
Aprotinin during coronary-artery bypass grafting and risk of death
@en
P2093
Alexander M Walker
Joan Landon
John D Seeger
Sebastian Schneeweiss
P304
P3181
P356
10.1056/NEJMOA0707571
P407
P577
2008-02-21T00:00:00Z